Schistosome resistance to praziquantel: Fact or artifact?

Parasitology Today

Volumn 12, Issue 8, 1996, Pages 316-320

  Fallon, Padraic G ^a   Tao, Liang Feng ^b   Ismail, Magdi M ^c   Bennett, James L ^d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^c Zagazig University   (Egypt)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYCANTHONE; METRIFONATE; OLTIPRAZ; OXAMNIQUINE; PRAZIQUANTEL;

ARTICLE; DRUG EFFICACY; DRUG RESISTANCE; HUMAN; SCHISTOSOMIASIS;

EID: 0030221878     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-4758(96)10029-6     Document Type: Article

References (32)

1. 1 Day, T.A. et al. (1992) Praziquantel: the enigmatic antiparasitic. Parasitol. Today 8, 342-344
2. 2 Redman, C.A. et al. (1995) Praziquantel: an urgent and exciting challenge. Parasitol. Today 12, 14-20
3. 3 Davis, A. (1993) in Human Schistosomiasis (Jordan, P., Webbe, G. and Sturrock, R.F., eds), pp 367-404, CAB International
4. 4 Cioli, D. et al. (1993) Drug resistance in schistosomes. Parasitol. Today 9, 162-166
5. 5 Brindley, P.J. (1994) Drug resistance to schistosomicides and other anthelmintics of medical importance. Acta Trop. 56, 213-231
6. 6 Prichard, R.K. et al. (1980) The problem of anthelmintic resistance in nematodes. Aust. Vet. J. 56, 239-250
7. 7 Kinoti, G.K. (1987) The significance of variation in the susceptibility of Schistosoma mansoni to the antischistosomal drug oxamniquine. Mem. Inst. Oswaldo Cruz 82, 151-156
8. 8 Sabah, A.A. et al. (1986) S. mansoni: Chemotherapy of infections of different ages. Exp. Parasitol. 61, 294-303
9. 9 Mehlhorn, H. et al. (1981) In vivo and in vitro experiments on the effects of praziquantel on S. mansoni: a light and electron microscopic study. Arzneimittel-Forschung 31, 544-554
10. 10 Delgado, V.S. et al. (1992) Experimental chemotherapy of S. mansoni with praziquantel and oxamniquine: differential effect of single or combined formulations of drugs on various strains and on both sexes of the parasite. Parasitol. Res. 78, 648-654
11. 11 Fallon, P.G. et al. (1994) Schistosoma mansoni: Praziquantel-induced exposure of alkaline phosphatase: drug-antibody synergy which acts preferentially against female worms. Parasite Immunol. 16, 529-536
12. 12 Fallon, P.G. and Doenhoff, M.J. (1995) Active-immunisation enhances efficacy of praziquantel treatment of Schistosoma mansoni. Parasite Immunol. 17, 261-268
13. 13 Fallon, P.G. et al. (1992) Immune-dependent chemotherapy of schistosomiasis. Parasitology 105, S41-S48
14. 14 Yue, W. et al. (1989) Relationship between the effects of praziquantel on mice and rabbits with different intensities of Schistosoma japonicum infection and humoral immunity levels of the host. Acta Pharmacol. Sinica 10, 476-479
15. 15 Fallon, P.G. et al. (1995) Correlation between drug cure-rates and intensity of murine Schistosoma mansoni-infection: role of antibody. Parasitology 111, 59-66
16. 16 Giboda, M. et al. (1992) Efficacy of praziquantel in treatment of schistosomiasis in a non-endemic country: a follow-up of parasitological, clinical and immunological parameters. J. Hyg. Epidemiol. Microbiol. Immunol. 36, 346-355
17. 17 Dias, L.C. and Olivier, C.E. (1986) Failure at inducing resistance to schistosomicidal drugs in a Brazilian human strain of S. mansoni. Rev. Inst. Med. Trop. Sao Paulo 28, 352-357
18. 18 Yue, W. et al. (1990) Failure to induce resistance of Schistosoma japonicum to praziquantel. S. E. Asian J. Trop. Med. Publ. Health 21, 85-89
19. 19 Fallon, P.G. and Doenhoff, M.J. (1994) Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am. J. Trop. Med. Hyg. 51, 83-88
20. 20 Ismail, M.M. et al. (1994) Laboratory induced resistance to praziquantel in experimental schistosomiasis. J. Egypt. Soc. Parasitol. 24, 685-695
21. 21 Brown, P. (1994) Deadly worm may be turning drug resistant. New Sci. 1951, 4
22. 22 Fallon, P.G. et al. (1995) Diminished praziquantel cure-rates in a Senegal isolate of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 53, 61-62
23. 23 Katz, N. et al. (1991) Efficacy of alternating therapy with oxamniquine and praziquantel to treat S. mansoni in children following failure of first treatment. Am. J. Trop. Med. Hyg. 44, 509-512
24. 24 Stelma, F.F. et al. (1995) Efficacy and side effects of praziquantel in an endemic focus of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 53, 167-170
25. 25 Gryseels, B. et al. (1994) Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal. Trop. Geogr. Med. 46, 209-219
26. 26 Van Gompel, A. et al. (1993) Laboratory infection with Schistosoma mansoni. Trans. R. Soc. Trop. Med. Hyg. 87, 554
27. 27 Metwally, A. et al. Impact of drug dosage and brand bioavailability and efficacy of praziquantel. Pharmacol. Res. (in press)
28. 28 Herwaldt, B.L. et al. (1995) Persistence of Schistosoma haematobium infection despite multiple courses of therapy with praziquantel. Clin. Infect. Dis. 20, 309-320
29. 29 Ismail, M. et al. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am. J. Trop. Med. Hyg. (in press)
30. 30 Yeang, F.S.W. et al. (1987) Oxamniquine resistance in S. mansoni: fact or fiction? Ann. Trop. Med. Parasitol. 81, 337-339
31. 31 Cioli, D et al. (1995) Antischistosomal drugs: past, present ... and future? Pharmacol. Ther. 68, 35-85
32. 32 Dias, L.C.S. et al. (1982) Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of S. mansoni to schistosomicidal agents. Trans. R. Soc. Trop. Med. Hyg. 76, 652-659